A Clinical Pharmacokinetics Study of NI-071.

Trial Profile

A Clinical Pharmacokinetics Study of NI-071.

Phase of Trial: Phase I

Latest Information Update: 09 Nov 2016

At a glance

  • Drugs Infliximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Nichi-Iko Pharmaceutical
  • Most Recent Events

    • 01 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top